Eesti -
eesti -
Ravimiamet
imavec 400 mg õhukese polümeerikattega tablett
helm ag - imatiniib - õhukese polümeerikattega tablett - 400mg 90tk; 400mg 30tk; 400mg 10tk
Eesti -
eesti -
Ravimiamet
imavec 100 mg õhukese polümeerikattega tablett
helm ag - imatiniib - õhukese polümeerikattega tablett - 100mg 20tk; 100mg 60tk; 100mg 120tk
Eesti -
eesti -
Ravimiamet
bendamustine sandoz infusioonilahuse kontsentraadi pulber
sandoz pharmaceuticals d.d. - bendamustiin - infusioonilahuse kontsentraadi pulber - 2,5mg 1ml 40ml 1tk; 2,5mg 1ml 10ml 5tk; 2,5mg 1ml 10ml 10tk; 2,5mg 1ml 40ml 5tk; 2,5mg 1ml 10ml 1tk; 2,5mg 1ml 10ml 20tk
Euroopa Liit -
eesti -
EMA (European Medicines Agency)
cinqaero
teva b.v. - reslizumab - astma - muud süsteemsed ravimid hingamisteede obstruktiivsete haiguste, - cinqaero on näidustatud täiendava ravina täiskasvanud patsientidel piisavalt kontrollitud, vaatamata kõrgete annuste inhaleeritavate kortikosteroidide pluss teise ravimi säilitusraviks raske eosinofiilse astmaga.
Euroopa Liit -
eesti -
EMA (European Medicines Agency)
nucala
glaxosmithkline trading services - mepolizumab - astma - ravimid hingamisteede obstruktiivsete haiguste, - severe eosinophilic asthmanucala is indicated as an add-on treatment for severe refractory eosinophilic asthma in adults, adolescents and children aged 6 years and older. chronic rhinosinusitis with nasal polyps (crswnp)nucala is indicated as an add-on therapy with intranasal corticosteroids for the treatment of adult patients with severe crswnp for whom therapy with systemic corticosteroids and/or surgery do not provide adequate control. eosinophilic granulomatosis with polyangiitis (egpa)nucala is indicated as an add-on treatment for patients aged 6 years and older with relapsing-remitting or refractory eosinophilic granulomatosis with polyangiitis (egpa). hypereosinophilic syndrome (hes)nucala is indicated as an add-on treatment for adult patients with inadequately controlled hypereosinophilic syndrome without an identifiable non-haematologic secondary cause.
Eesti -
eesti -
Ravimiamet
alphalben suukaudne suspensioon
alpha-vet kft. - albendasool - suukaudne suspensioon - 100mg 1ml 1000ml 1tk
Eesti -
eesti -
Ravimiamet
zantel tablett
chanelle pharmaceuticals manufacturing limited - prasikvanteel+fenbendasool - tablett - 50mg+500mg 50tk; 50mg+500mg 100tk; 50mg+500mg 20tk
Eesti -
eesti -
Ravimiamet
ecomectin süstelahus
eco animal health europe limited - ivermektiin - süstelahus - 10mg 1ml 250ml 1tk; 10mg 1ml 50ml 1tk
Euroopa Liit -
eesti -
EMA (European Medicines Agency)
panacur aquasol
intervet international bv - fenbendasool - anthelminti, , bensimidasoolid ja nendega seotud ained, fenbendazole - pigs; chicken - raviks ja kontrolli seedetrakti ümarusse sigadel nakatunud:ascaris suum (täiskasvanud, soole ja rändavad vastsete etapis);oesophagostomum spp.. (täiskasvanud etapis);trichuris suis (täiskasvanud etapid). ravi seedetrakti ümarusse kanade nakatunud:ascaridia galli (l5 ja täiskasvanud etapis);heterakis gallinarum ' i suhtes (l5 ja täiskasvanud etapis);capillaria spp. (l5 ja täiskasvanud etapid).
Eesti -
eesti -
Ravimiamet
prazitel plus tablett
chanelle pharmaceuticals manufacturing limited - prasikvanteel+febanteel+püranteel - tablett - 50mg+150mg+50mg 80tk; 50mg+150mg+50mg 42tk; 50mg+150mg+50mg 280tk; 50mg+150mg+50mg 48tk; 50mg+150mg+50mg 16tk; 50mg+150mg+50mg 32tk; 50mg+150mg+50mg 12tk; 50mg+150mg+50mg 104tk; 50mg+150mg+50mg 1000tk; 50mg+150mg+50mg 140tk; 50mg+150mg+50mg 180tk; 50mg+150mg+50mg 14tk; 50mg+150mg+50mg 120tk; 50mg+150mg+50mg 204tk; 50mg+150mg+50mg 30tk; 50mg+150mg+50mg 44tk; 50mg+150mg+50mg 10tk; 50mg+150mg+50mg 6tk; 50mg+150mg+50mg 36tk; 50mg+150mg+50mg 4tk; 50mg+150mg+50mg 250tk; 50mg+150mg+50mg 20tk; 50mg+150mg+50mg 56tk; 50mg+150mg+50mg 60tk; 50mg+150mg+50mg 90tk; 50mg+150mg+50mg 18tk; 50mg+150mg+50mg 70tk; 50mg+150mg+50mg 8tk; 50mg+150mg+50mg 100tk; 50mg+150mg+50mg 24tk; 50mg+150mg+50mg 106tk; 50mg+150mg+50mg 2tk; 50mg+150mg+50mg 150tk; 50mg+150mg+50mg 300tk; 50mg+150mg+50mg 40tk; 50mg+150mg+50mg 50tk; 50mg+150mg+50mg 200tk